ENDEFR
Home › United Kingdom › CANCER RESEARCH TECHNOLOGY LIMITED

CANCER RESEARCH TECHNOLOGY LIMITED

Private Limited Company (Ltd) · LONDON, United Kingdom · LEI 21380044FRQ2UIJN7A22
LEI active

Summary

CANCER RESEARCH TECHNOLOGY LIMITED is registered in the United Kingdom and entered in the “Companies House register” under number 01626049. Its legal form is Private Limited Company (Ltd). According to GLEIF, its ultimate parent is CANCER RESEARCH UK (United Kingdom), which is also its direct parent. That group has 2 subsidiaries with LEIs in 1 country, 2 of them in the United Kingdom. The LEI was first issued on 3 Feb 2014 and the record was last updated on 21 Jan 2026; the next renewal is due by 8 Feb 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formPrivate Limited Company (Ltd)
RegisterCompanies House register · Register website
Registration number01626049
Registration authorityCompanies House
JurisdictionUnited Kingdom
Registered address2 REDMAN PLACE, E20 1JQ LONDON, United Kingdom
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)31 Mar 1982
LEI21380044FRQ2UIJN7A22
LEI statusactive
LEI first issued3 Feb 2014
LEI record last updated21 Jan 2026
Next LEI renewal8 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

CANCER RESEARCH UK United Kingdom ultimate parent
CANCER RESEARCH TECHNOLOGY LIMITED this entity
View the whole group: 2 subsidiaries in 1 countries

Relationship to the parent

Direct parentUltimate parent
ParentCANCER RESEARCH UKCANCER RESEARCH UK
Accounting period1 Apr 2024 to 31 Mar 20251 Apr 2024 to 31 Mar 2025
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardother standardother standard
Relationship start26 Jan 201826 Jan 2018
Recorded at GLEIF since3 Feb 20143 Feb 2014
Last updated21 Jan 202621 Jan 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (1)